Showing results (451-460 of 6,497) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|May 22, 2015
Label-free quantitative mass spectrometry for analysis of protein antigens in a meningococcal group B outer membrane vesicle vaccineLawrence W Dick, John T Mehl, John W Loughney, et al.Human Vaccines & Immunotherapeutics|May 22, 2015
A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulationSepideh Aboutorabian, Jalil Hakimi, Florence Boudet, et al.Human Vaccines & Immunotherapeutics|April 28, 2015
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodiesRoger H Brookes, Marin Ming, Kimberley Williams, et al.Human Vaccines & Immunotherapeutics|April 28, 2015
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysisShi-Yuan Wang, Xiao-Hua Cheng, Jing-Xin Li, et al.Human Vaccines & Immunotherapeutics|May 29, 2015
Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatmentYue Zhang, Min Li, Fan Yang, et al.Human Vaccines & Immunotherapeutics|May 29, 2015
Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45P Vijayachari, K Vedhagiri, K Mallilankaraman, et al.Human Vaccines & Immunotherapeutics|May 22, 2015
Oncolytic viruses: From bench to bedside with a focus on safetyPascal R A Buijs, Judith H E Verhagen, Casper H J van Eijck, et al.Human Vaccines & Immunotherapeutics|May 22, 2015
Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysisOlivier Van Der Meeren, Priya Crasta, Brigitte Cheuvart, et al.Human Vaccines & Immunotherapeutics|May 22, 2015
Persistence of immunity in healthy adults aged ≥ 50 years primed with a hepatitis B vaccine 3 years previouslyRajiv Sharma, Clas Ahlm, Lars Ostergaard, et al.Human Vaccines & Immunotherapeutics|April 23, 2015
Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine developmentMuna F Abry, Kelvin M Kimenyi, Fred O Osowo, et al.Pageof 650